BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31742408)

  • 1. Antibody-Drug Conjugates with Indolinobenzodiazepine Dimer Payloads: DNA-Binding Mechanism of Indolinobenzodiazepine Dimer Catabolites in Target Cancer Cells.
    Singh R; Reid EE; Harris L; Salomon PL; Miller ML; Chari RVJ; Keating TA
    Mol Pharm; 2020 Jan; 17(1):50-58. PubMed ID: 31742408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of Highly Potent N-10 Amino-Linked DNA-Alkylating Indolinobenzodiazepine Antibody-Drug Conjugates (ADCs).
    Archer KE; Reid EE; Shizuka M; Woods J; Harris L; Maloney EK; Bartle LM; Ab O; Wilhelm A; Setiady Y; Ponte JF; Singh R; Keating TA; Chari RVJ; Miller ML
    ACS Med Chem Lett; 2019 Aug; 10(8):1211-1215. PubMed ID: 31413807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Variation of Pyrrolobenzodiazepine (PBD)-Dimer Payload Physicochemical Properties Impacts Efficacy and Tolerability of the Corresponding Antibody-Drug Conjugates.
    Staben LR; Chen J; Cruz-Chuh JD; Del Rosario G; Go MA; Guo J; Khojasteh SC; Kozak KR; Li G; Ng C; Lewis Phillips GD; Pillow TH; Rowntree RK; Wai J; Wei B; Xu K; Xu Z; Yu SF; Zhang D; Dragovich PS
    J Med Chem; 2020 Sep; 63(17):9603-9622. PubMed ID: 32787101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and Catabolism of [
    Bolleddula J; Shah A; Shadid M; Kamali A; Smith MD; Chowdhury SK
    Drug Metab Dispos; 2020 Nov; 48(11):1239-1245. PubMed ID: 32843329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Specific ATP-Binding Cassette Transporters in the Acquired Resistance to Pyrrolobenzodiazepine Dimer-Containing Antibody-Drug Conjugates.
    Corbett S; Huang S; Zammarchi F; Howard PW; van Berkel PH; Hartley JA
    Mol Cancer Ther; 2020 Sep; 19(9):1856-1865. PubMed ID: 32669316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter- and intrastrand DNA crosslinks by 2-fluoro-substituted pyrrolobenzodiazepine dimers: stability, stereochemistry and drug orientation.
    Seifert J; Pezeshki S; Kamal A; Weisz K
    Org Biomol Chem; 2012 Sep; 10(34):6850-60. PubMed ID: 22837138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covalent Bonding of Pyrrolobenzodiazepines (PBDs) to Terminal Guanine Residues within Duplex and Hairpin DNA Fragments.
    Mantaj J; Jackson PJ; Karu K; Rahman KM; Thurston DE
    PLoS One; 2016; 11(4):e0152303. PubMed ID: 27055050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological Malignancies.
    Flynn MJ; Zammarchi F; Tyrer PC; Akarca AU; Janghra N; Britten CE; Havenith CE; Levy JN; Tiberghien A; Masterson LA; Barry C; D'Hooge F; Marafioti T; Parren PW; Williams DG; Howard PW; van Berkel PH; Hartley JA
    Mol Cancer Ther; 2016 Nov; 15(11):2709-2721. PubMed ID: 27535974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and evaluation of novel, potent DNA alkylating agents and their antibody-drug conjugates (ADCs).
    Reid EE; Archer KE; Shizuka M; McShea MA; Maloney EK; Ab O; Lanieri L; Wilhelm A; Ponte JF; Yoder NC; Chari RVJ; Miller ML
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2455-2458. PubMed ID: 31350125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of base sequence on the DNA cross-linking properties of pyrrolobenzodiazepine (PBD) dimers.
    Rahman KM; James CH; Thurston DE
    Nucleic Acids Res; 2011 Jul; 39(13):5800-12. PubMed ID: 21427082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-drug conjugates (ADCs) delivering pyrrolobenzodiazepine (PBD) dimers for cancer therapy.
    Hartley JA
    Expert Opin Biol Ther; 2021 Jul; 21(7):931-943. PubMed ID: 32543981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engineered antibody and a dual-maleimide pyrrolobenzodiazepine dimer.
    White JB; Fleming R; Masterson L; Ruddle BT; Zhong H; Fazenbaker C; Strout P; Rosenthal K; Reed M; Muniz-Medina V; Howard P; Dixit R; Wu H; Hinrichs MJ; Gao C; Dimasi N
    MAbs; 2019 Apr; 11(3):500-515. PubMed ID: 30835621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrrolobenzodiazepine Dimer Antibody-Drug Conjugates: Synthesis and Evaluation of Noncleavable Drug-Linkers.
    Gregson SJ; Masterson LA; Wei B; Pillow TH; Spencer SD; Kang GD; Yu SF; Raab H; Lau J; Li G; Lewis Phillips GD; Gunzner-Toste J; Safina BS; Ohri R; Darwish M; Kozak KR; Dela Cruz-Chuh J; Polson A; Flygare JA; Howard PW
    J Med Chem; 2017 Dec; 60(23):9490-9507. PubMed ID: 29112410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirine.
    Hartley JA; Flynn MJ; Bingham JP; Corbett S; Reinert H; Tiberghien A; Masterson LA; Antonow D; Adams L; Chowdhury S; Williams DG; Mao S; Harper J; Havenith CEG; Zammarchi F; Chivers S; van Berkel PH; Howard PW
    Sci Rep; 2018 Jul; 8(1):10479. PubMed ID: 29992976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-Drug Conjugates Derived from Cytotoxic seco-CBI-Dimer Payloads Are Highly Efficacious in Xenograft Models and Form Protein Adducts In Vivo.
    Su D; Chen J; Cosino E; Dela Cruz-Chuh J; Davis H; Del Rosario G; Figueroa I; Goon L; He J; Kamath AV; Kaur S; Kozak KR; Lau J; Lee D; Lee MV; Leipold D; Liu L; Liu P; Lu GL; Nelson C; Ng C; Pillow TH; Polakis P; Polson AG; Rowntree RK; Saad O; Safina B; Stagg NJ; Tercel M; Vandlen R; Vollmar BS; Wai J; Wang T; Wei B; Xu K; Xue J; Xu Z; Yan G; Yao H; Yu SF; Zhang D; Zhong F; Dragovich PS
    Bioconjug Chem; 2019 May; 30(5):1356-1370. PubMed ID: 30966735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and evaluation of new noncross-linking pyrrolobenzodiazepine dimers with efficient DNA binding ability and potent antitumor activity.
    Kamal A; Ramesh G; Laxman N; Ramulu P; Srinivas O; Neelima K; Kondapi AK; Sreenu VB; Nagarajaram HA
    J Med Chem; 2002 Oct; 45(21):4679-88. PubMed ID: 12361394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of pyrrolobenzodiazepines and related covalent-binding DNA-interactive molecules as ADC payloads: Is mechanism related to systemic toxicity?
    Jackson PJM; Kay S; Pysz I; Thurston DE
    Drug Discov Today Technol; 2018 Dec; 30():71-83. PubMed ID: 30553523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Pyrrolobenzodiazepine Dimer Bis-imine versus Mono-imine: DNA Interstrand Cross-linking, Cytotoxicity, Antibody-Drug Conjugate Efficacy and Toxicity.
    Tiberghien AC; Vijayakrishnan B; Esfandiari A; Ahmed M; Pardo R; Bingham J; Adams L; Santos K; Kang GD; Pugh KM; Afif-Rider S; Vashisht K; Haque K; Tammali R; Rosfjord E; Savoca A; Hartley JA; Howard PW
    Mol Cancer Ther; 2023 Feb; 22(2):254-263. PubMed ID: 36722141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of molecular dynamics simulations to evaluate the DNA sequence-selectivity of G-A cross-linking PBD-duocarmycin dimers.
    Jackson PJM; Rahman KM; Thurston DE
    Bioorg Med Chem Lett; 2017 Jan; 27(1):102-108. PubMed ID: 27889454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observation of a single-stranded DNA/pyrrolobenzodiazepine adduct.
    Rahman KM; James CH; Bui TT; Drake AF; Thurston DE
    J Am Chem Soc; 2011 Dec; 133(48):19376-85. PubMed ID: 21928841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.